Breaking News
Quotes
All Instrument Types
  • All Instrument Types
  • Indices
  • Equities
  • ETFs
  • Funds
  • Commodities
  • Currencies
  • Crypto
  • Bonds
  • Certificates

Please try another search

Search website for: 
Popular News
More
Popular Analysis
More
More
Get 40% Off
/Free Sign Up
 0
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks
Close

Siemens Healthineers AG (SHLG)

Create Alert
Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Create Manage my alerts 
Back
Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
 
Create New Watchlist Create
Create a new holdings portfolio Add Create
+ Add another position Close
52.08 -0.38    -0.72%
18:32:23 - Closed. Currency in EUR ( Disclaimer )
  • Volume: 28
  • Bid/Ask: 52.20 / 52.50
  • Day's Range: 52.08 - 53.04
Type:  Equity
Market:  Germany
ISIN:  DE000SHL1006 
S/N:  SHL100
Siemens Healthineers 52.08 -0.38 -0.72%

SHLG Income Statement & Profits

 
Assess the Siemens Healthineers AG income statement, view the company's financial performance across their assets and liabilities. Select to view either quarterly or annual data.
AnnualQuarterly
InvestingPro Advanced Income Statement
Collapse All
Period Ending: 2022
31/03
 2021
31/12
 2021
30/09
 2021
30/06
Total Revenue 5460 5068 5164 5000
Revenue 5460 5068 5164 5000
Other Revenue, Total - - - -
Cost of Revenue, Total 3421 3161 3205 3079
Gross Profit 2039 1907 1959 1921
Total Operating Expenses 4700 4376 4542 4328
Selling/General/Admin. Expenses, Total 826 803 855 843
Research & Development 444 408 483 403
Depreciation / Amortization - - - -
Interest Expense (Income) - Net Operating - -2 -5 -
Unusual Expense (Income) - - - -
Other Operating Expenses, Total 9 6 4 3
Operating Income 760 692 622 672
Interest Income (Expense), Net Non-Operating -13 -16 -13 -13
Gain (Loss) on Sale of Assets - - - -
Other, Net 7 -15 -13 -73
Net Income Before Taxes 754 661 596 586
Provision for Income Taxes 170 190 130 191
Net Income After Taxes 584 471 466 395
Minority Interest -5 -6 -3 -5
Equity In Affiliates - - - -
U.S GAAP Adjustment - - - -
Net Income Before Extraordinary Items 579 465 463 390
Total Extraordinary Items - - - -
Net Income 579 465 463 390
Total Adjustments to Net Income - 1 -2 -
Income Available to Common Excluding Extraordinary Items 579 466 461 390
Dilution Adjustment - - - -
Diluted Net Income 579 466 461 390
Diluted Weighted Average Shares 1110.73 1136.59 1128.45 1114.29
Diluted EPS Excluding Extraordinary Items 0.52 0.41 0.41 0.35
DPS - Common Stock Primary Issue - - 0.85 -
Diluted Normalized EPS 0.55 0.42 0.42 0.36
* In Millions of (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on the income statement, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

I Agree

SHLG Price Commentary

Write your thoughts about Siemens Healthineers AG
 
Are you sure you want to delete this chart?
Delete Cancel
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
Replace Cancel
1000
Comment Guidelines
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
Delete Cancel
 
Post
 
Replace the attached chart with a new chart ?
Replace Cancel
1000
Comment Guidelines
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Cancel Attach
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Confirm Block Cancel
Ok
Report this comment

I feel that this comment is:

Submit
Comment flagged

Thank You!

Your report has been sent to our moderators for review
Close
Continue with Google
or
Sign up with Email